Marco Gianfriddo

1.7k total citations
21 papers, 1.3k citations indexed

About

Marco Gianfriddo is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Marco Gianfriddo has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 8 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Marco Gianfriddo's work include Neuroscience and Neuropharmacology Research (10 papers), Adenosine and Purinergic Signaling (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Marco Gianfriddo is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Adenosine and Purinergic Signaling (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Marco Gianfriddo collaborates with scholars based in Italy, United Kingdom and Japan. Marco Gianfriddo's co-authors include Felicita Pedata, Alessia Melani, Maria Giuliana Vannucchi, Sara Cipriani, Georg C. Terstappen, Carla Scali, Andrea Caricasole, Renza Roncarati, G. Gaviraghi and Cinzia Volonté and has published in prestigious journals such as Neurology, Brain Research and The FASEB Journal.

In The Last Decade

Marco Gianfriddo

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Gianfriddo Italy 17 506 503 496 363 190 21 1.3k
Fabio Cavaliere Spain 27 862 1.7× 693 1.4× 610 1.2× 581 1.6× 524 2.8× 45 2.2k
Chiara Cervetto Italy 21 238 0.5× 432 0.9× 583 1.2× 143 0.4× 145 0.8× 54 1.1k
Joel B. Schachter United States 24 682 1.3× 461 0.9× 860 1.7× 185 0.5× 783 4.1× 35 2.0k
Kristof Van Kolen Belgium 18 164 0.3× 268 0.5× 455 0.9× 184 0.5× 531 2.8× 32 1.1k
Paulo F. Santos Portugal 24 268 0.5× 473 0.9× 632 1.3× 377 1.0× 92 0.5× 45 1.3k
Jon P. Hatcher United Kingdom 11 211 0.4× 442 0.9× 439 0.9× 197 0.5× 536 2.8× 11 1.2k
Edward Beamer Ireland 17 286 0.6× 308 0.6× 230 0.5× 160 0.4× 88 0.5× 22 773
David J. Hinton United States 19 146 0.3× 408 0.8× 299 0.6× 145 0.4× 176 0.9× 30 891
Brian Pearce United Kingdom 21 172 0.3× 895 1.8× 826 1.7× 287 0.8× 284 1.5× 34 1.4k
Elena Bastia Italy 15 342 0.7× 420 0.8× 418 0.8× 130 0.4× 159 0.8× 27 1.1k

Countries citing papers authored by Marco Gianfriddo

Since Specialization
Citations

This map shows the geographic impact of Marco Gianfriddo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Gianfriddo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Gianfriddo more than expected).

Fields of papers citing papers by Marco Gianfriddo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Gianfriddo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Gianfriddo. The network helps show where Marco Gianfriddo may publish in the future.

Co-authorship network of co-authors of Marco Gianfriddo

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Gianfriddo. A scholar is included among the top collaborators of Marco Gianfriddo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Gianfriddo. Marco Gianfriddo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashimoto, Yuichi, Hiroaki Suzuki, Marco Gianfriddo, et al.. (2011). VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. The FASEB Journal. 25(6). 1983–2000. 28 indexed citations
2.
Pitozzi, Vanessa, Michela Jacomelli, Cristina Luceri, et al.. (2010). Effects of dietary extra-virgin olive oil on behaviour and brain biochemical parameters in ageing rats. British Journal Of Nutrition. 103(11). 1674–1683. 48 indexed citations
3.
Roncarati, Renza, Carla Scali, Thomas A. Comery, et al.. (2009). Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders. Journal of Pharmacology and Experimental Therapeutics. 329(2). 459–468. 88 indexed citations
4.
Rosi, Maria Cristina, Ilaria Luccarini, Cristina Grossi, et al.. (2009). Increased Dickkopf‐1 expression in transgenic mouse models of neurodegenerative disease. Journal of Neurochemistry. 112(6). 1539–1551. 148 indexed citations
5.
Pugliese, Anna Maria, Chiara Traini, Sara Cipriani, et al.. (2009). The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen‐glucose deprivation in rat CA1 hippocampal slices. British Journal of Pharmacology. 157(5). 818–830. 51 indexed citations
6.
Fecke, Wolfgang, Marco Gianfriddo, G. Gaviraghi, Georg C. Terstappen, & Freddy Heitz. (2009). Small molecule drug discovery for Huntington's Disease. Drug Discovery Today. 14(9-10). 453–464. 34 indexed citations
7.
Cipriani, Sara, et al.. (2008). Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice. Experimental Neurology. 213(1). 163–170. 20 indexed citations
10.
Scali, Carla, Filippo Caraci, Marco Gianfriddo, et al.. (2006). Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiology of Disease. 24(2). 254–265. 110 indexed citations
11.
Melani, Alessia, Marco Gianfriddo, Maria Giuliana Vannucchi, et al.. (2006). The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Research. 1073-1074. 470–480. 80 indexed citations
12.
Melani, Alessia, Susanna Amadio, Marco Gianfriddo, et al.. (2006). P2X7Receptor Modulation on Microglial Cells and Reduction of Brain Infarct Caused by Middle Cerebral Artery Occlusion in Rat. Journal of Cerebral Blood Flow & Metabolism. 26(7). 974–982. 124 indexed citations
13.
Pedata, Felicita, et al.. (2005). The protective effect of adenosine A2Areceptor antagonism in cerebral ischemia. Neurological Research. 27(2). 169–174. 42 indexed citations
14.
Vannucchi, Maria Giuliana, et al.. (2005). Expression of neuronal and inducible nitric oxide synthase in neuronal and glial cells after transient occlusion of the middle cerebral artery. Neuroscience. 136(4). 1015–1026. 14 indexed citations
15.
Melani, Alessia, et al.. (2005). ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochemistry International. 47(6). 442–448. 219 indexed citations
17.
Corsi, Claudia, Annalisa Pinna, Marco Gianfriddo, et al.. (2003). Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. European Journal of Pharmacology. 464(1). 33–38. 45 indexed citations
18.
Gianfriddo, Marco, Claudia Corsi, Alessia Melani, et al.. (2003). Adenosine A2A antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington’s disease. Brain Research. 979(1-2). 225–229. 13 indexed citations
19.
Pedata, Felicita, Anna Maria Pugliese, Alessia Melani, & Marco Gianfriddo. (2003). Introduction: A 2A receptors in neuroprotection of dopaminergic neurons. Neurology. 61(11_suppl_6). S49–50. 13 indexed citations
20.
Melani, Alessia, Leonardo Pantoni, Francesca Bordoni, et al.. (2002). The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Research. 959(2). 243–250. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026